Preparation of a novel liver-targeting nanoparticle of norcantharidin derivative and evaluation of its anti-tumour activity

References

• Wang , GS . 1989 . Medical uses of Mylabris in ancient China and recent studies . J. Ethnopharmacol. , 26 ( 2 ) : 147 – 162 .
   PubMed Web of Science ®Google Scholar
• Liu , X , Paul , WSH , Li , Q and Chan , LW . 2006 . Novel polymeric microspheres containing norcantharidin for chemoembolization . J. Control Release , 116 ( 1 ) : 35 – 41 .
   PubMed Web of Science ®Google Scholar
• Liu , XH , Blazsek , I , Comisso , M , Legras , S , Marion , S , Quittet , P , Anjo , A , Wang , GS and Misset , JL . 1995 . Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells . Eur. J. Cancer , 31A ( 6 ) : 953 – 963 .
   PubMedGoogle Scholar
• Wang , GS . 1983 . Hydrolyze of norcantharidin and subtracting methyla alleviate stimulation of renal system . Chin. Pharm. Bull. , 18 ( 7 ) : 18 – 20 .
   Google Scholar
• Wang , LX , He , HB , Tang , X , Shao , RY and Chen , DW . 2006 . A less irritant norcantharidin lipid microspheres: Formulation and drug distribution . Int. J. Pharm. , 323 ( 1–2 ) : 161 – 167 .
   PubMedGoogle Scholar
• Zhang , W , Gong , JH and Zhang , XN . 2008 . Multi-variable regression analysis applied to synchronously optimize preparation of nanoparticles . Chin. Pharm. J. , 43 ( 15 ) : 1162 – 1166 .
   Google Scholar
• Zhang , W , Liu , Y and Zhang , XN . 2008 . Spatial representable structure and release in vitro of low molecular weight (LMW) chitosan nanoparticles loading-norcantharidin . Chinese Traditional and Herbal Drugs , 39 ( 10 ) : 4 – 9 .
   Google Scholar
• Li , Y , Huang , G , Diakur , J and Wiebe , LI . 2008 . Targeted delivery of macromolecular drugs: Asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development . Curr. Drug Deliv. , 5 ( 4 ) : 299 – 302 .
   PubMedGoogle Scholar
• Morell , AG , Irvine , RA , Sternlieb , I , Scheinberg , IH and Ashwell , G . 1968 . Physical and chemical studies on ceruloplasmin: V. Metabolic studies on sialic acid-free ceruloplasmin in vivo . J. Biol. Chem. , 243 ( 1 ) : 155 – 159 .
   PubMedGoogle Scholar
• Horev , O , Stokmaier , D , Schwardt , O , Cutting , B and Ernst , B . 2008 . Trivalent, Gal/GalNAc-containing ligands designed for the asialoglycoprotein receptor . Bioorg. Med. Chem. , 16 ( 9 ) : 5216 – 5231 .
   PubMedGoogle Scholar
• Spiess , M . 1990 . The asialoglycoprotein receptor: A model for endocytic transport receptors . Biochemistry , 29 ( 43 ) : 10009 – 10018 .
   PubMed Web of Science ®Google Scholar
• Bettinger , T , Remy , JS and Erbacher , P . 1999 . Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes . Bioconjug. Chem. , 10 ( 4 ) : 558 – 561 .
   PubMedGoogle Scholar
• Brigger , I , Dubernet , C and Couvreur , P . 2002 . Nanoparticles in cancer therapy and diagnosis . Adv. Drug Deliv. Rev. , 54 ( 5 ) : 631 – 651 .
   PubMed Web of Science ®Google Scholar
• Niidome , T , Urakawa , M , Sato , H , Takahara , Y , Anai , T , Hatakayama , T , Wada , A , Hirayama , T and Aoyagi , H . 2000 . Gene transfer into hepatoma cells mediated by galactosemodified alpha-helical peptides . Biomaterials , 21 ( 17 ) : 1811 – 1819 .
   PubMedGoogle Scholar
• Hattori , Y , Kawakami , S , Yamashita , F and Hashida , M . 2000 . Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting . J. Control. Release , 69 ( 3 ) : 369 – 377 .
   PubMed Web of Science ®Google Scholar
• Kawakami , S , Wong , J , Sato , A , Hattori , Y , Yamashita , F and Hashida , M . 2000 . Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice . Biochim. Biophys. Acta , 1524 ( 2–3 ) : 258 – 265 .
   PubMed Web of Science ®Google Scholar
• Ruocco , LA , Viggiano , D , Viggiano , A , Abignente , E , Rimoli , MG , Melisi , D , Curcio , A , Nieddu , M , Boatto , G , Carboni , E , Gironi Carnevale , UA and Sadile , AG . 2008 . Galactosylated dopamine enters into the brain, blocks the mesocorticolimbic system and modulates activity and scanning time in Naples high excitability rats . Neuroscience , 152 ( 1 ) : 234 – 244 .
   PubMedGoogle Scholar
• Xu , ZH , Chen , L , Gu , WW , Gao , Y , Lin , LP , Zhang , ZW , Xi , Y and Li , YP . 2008 . The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma . Biomaterials , 30 ( 2 ) : 226 – 232 .
   PubMedGoogle Scholar
• Maitani , Y , Kawano , K , Yamada , K , Nagai , T and Takayama , K . 2001 . Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells . J. Control. Release , 75 ( 3 ) : 381 – 389 .
   PubMed Web of Science ®Google Scholar
• Wang , SN , Deng , YH , Xu , H , Wu , HB , Qiu , YK and Chen , DW . 2006 . Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin . Eur. J. Pharm. Biopharm. , 62 ( 1 ) : 32 – 38 .
   PubMed Web of Science ®Google Scholar
• Williams , TJ , Plessas , NR , Goldstein , IJ and Lönngren , J . 1979 . A new class of model glycolipids: Synthesis, characterization, and interaction with lectins . Arch. Biochem. Biophys. , 195 ( 1 ) : 145 – 151 .
   PubMed Web of Science ®Google Scholar
• Mantovani , G , Lecolley , F , Tao , L , Haddleton , DM , Clerx , J , Cornelissen , JJ and Velonia , K . 2005 . Design and synthesis of N-maleimido-functionalized hydrophilic polymers via copper-mediated living radical polymerization: A suitable alternative to PEGylation chemistry . J. Am. Chem. Soc. , 127 ( 9 ) : 2966 – 2973 .
   PubMed Web of Science ®Google Scholar
• Calvo , P , Remuñan-López , C , Vila-Jato , JL and Alonso , MJ . 1997 . Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer NPs as novel carriers for proteins and vaccines . Pharm. Res. , 14 ( 10 ) : 1431 – 1436 .
   PubMed Web of Science ®Google Scholar
• Yang , Z-Q , Xu , J , Pan , P and Zhang , X-N . 2008 . Preparation of an alternative freeze-dried PH-sensitive cyclosporine A nanoparticle formulation and its pharmacokinetic profile in rats . Pharmazie , 63 ( 6 ) : 26 – 31 .
   Google Scholar
• Teng , B-S , Lu , Y-H , Wang , Z-T , Tao , X-Y and Wei , D-Z . 2006 . In vitro anti-tumor activity of isorhamnetin isolated from Hippophae rhamnoides L against BEL-7402 cells . Pharm. Res. , 54 ( 3 ) : 186 – 194 .
   Google Scholar
• Kim , CK , Min , KH , Oh , YK , Park , KM and Kim , KM . 1996 . Preparation and lectin binding characteristics of N-stearyl lactobionamide liposomes . Intern. J. Pharm. , 128 ( 1–2 ) : 65 – 71 .
   Google Scholar
• Liang , HF , Yang , TF , Huang , CT , Chen , MC and Sung , HW . 2005 . Preparation of nanoparticles composed of poly(gamma-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells . J. Control. Release , 105 ( 30 ) : 213 – 225 .
   PubMedGoogle Scholar
• Wu , J and Zern , MA . 1996 . Modification of liposomes for liver targeting . J. Hepatol. , 24 ( 6 ) : 757 – 763 .
   PubMedGoogle Scholar
• Wu , J , Liu , L , Yen , R , Le , HT , Zern , MA , Nantz , MH and Marklund , SL . 2003 . Polycationic liposome-mediated extracellular superoxide dismutase gene delivery prevents acute liver injury in mice . Hepatology , 38 ( 1 ) : 240 – 241 .
   Google Scholar
• Wu , J and Zern , MA . 2004 . Tissue transglutaminase, a key enzyme involved in liver diseases . Hepatol. Res. , 29 ( 1 ) : 1 – 8 .
   PubMedGoogle Scholar
• Gao , S , Chen , J , Xu , X , Ding , Z , Yang , Y-H , Hua , Z and Zhang , J . 2003 . Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting . Int. J. Pharm. , 255 ( 1–2 ) : 57 – 68 .
   PubMedGoogle Scholar
• Maitani , Y , Kawano , K , Yamada , K , Nagai , T and Takayama , K . 2001 . Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells . J. Control. Release , 75 ( 3 ) : 381 – 389 .
   PubMed Web of Science ®Google Scholar
• Stewart , SG , Hill , TA , Gilbert , J , Ackland , SP , Sakoff , JA and McCluskey , A . 2007 . Synthesis and biological evaluation of norcantharidin analogues: Towards PP1 selectivity . Bioorg. Med. Chem. , 15 ( 23 ) : 7301 – 7310 .
   PubMedGoogle Scholar
• Hill , TA , Stewart , SG , Ackland , SP , Gilbert , J , Sauer , B , Sakoff , JA and McCluskey , A . 2007 . Norcantharimides, synthesis and anticancer activity: Synthesis of new norcantharidin analogues and their anticancer evaluation . Bioorg. Med. Chem. , 15 ( 18 ) : 6126 – 6134 .
   PubMedGoogle Scholar
• Hill , TA , Stewart , SG , Sauer , B , Gilbert , J , Ackland , SP , Sakoff , JA and McCluskey , A . 2007 . Heterocyclic substituted cantharidin and norcantharidin analogues—synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity . Bioorg. Med. Chem. , 17 ( 12 ) : 3392 – 3397 .
   Google Scholar
• Byrne , JD , Betancourt , T and Brannon-Peppas , L . 2008 . Active targeting schemes for nanoparticle systems in cancer therapeutics . Adv. Drug Deliv. Rev. , 60 ( 15 ) : 1615 – 1626 .
   PubMed Web of Science ®Google Scholar
• Shimura , N , Sogawa , Y , Kawakita , Y , Ikekita , M , Yamazaki , N and Kojima , S . 2002 . Radioiodination of glycoprotein-conjugated liposomes by using the Bolton-Hunter reagent and biodistribution in tumor-bearing mice . Nucl. Med. Biol. , 29 ( 4 ) : 491 – 496 .
   PubMedGoogle Scholar
• Xiong , XB , Huang , Y , Lu , WL , Zhang , X , Zhang , H , Nagai , TJ and Zhang , Q . 2005 . Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic . J. Control. Release , 107 ( 2–3 ) : 262 – 275 .
   PubMedGoogle Scholar
• Bodnar , M and Foryś , U . 2009 . A model of immune system with time-dependent immune reactivity . Nonlinear Anal. Theory Methods Appl. , 70 ( 2 ) : 1049 – 1058 .
   Web of Science ®Google Scholar